Nolwenn Martin

Title: Nolwenn Martin: Innovator in Pharmaceutical Science

Introduction

Nolwenn Martin is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. With a total of four patents to his name, Martin's work focuses on improving the efficacy and delivery of medications.

Latest Patents

One of Nolwenn Martin's latest patents is titled "Amorphous solid dispersion of an orally available gonadotropin-releasing hormone receptor antagonist." This invention relates to an amorphous solid dispersion that includes elagolix sodium and at least one silicon-based inorganic compound. The patent also describes a process for preparing this solid dispersion, which can be utilized in a pharmaceutical composition for treating conditions such as endometriosis and uterine fibroids. Another significant patent is for the "Crystalline form of masitinib," which pertains to a polymorphic form of masitinib mesylate, along with processes for its preparation and medical applications.

Career Highlights

Throughout his career, Nolwenn Martin has worked with prominent companies in the pharmaceutical industry, including Sandoz AG. His expertise in drug formulation and development has positioned him as a valuable asset in the field.

Collaborations

Nolwenn has collaborated with several professionals, including Diana Fischer-Daut and Josef Wieser. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Nolwenn Martin's contributions to pharmaceutical science through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective treatments for various medical conditions.